ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
2 |
2
|
2009 |
2010 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.020 |
None |
0.500 |
2 |
|
2017 |
2018 |
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
543
|
432
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2438
|
563
|
0.110 |
None |
0.500 |
2 |
1
|
2009 |
2016 |
Adenoid Cystic Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
325
|
30
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2013 |
Age related macular degeneration
|
disease |
Eye Diseases
|
Disease or Syndrome
|
685
|
663
|
0.110 |
None |
< 0.001 |
1 |
2
|
2012 |
2012 |
AIDS, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
2 |
2
|
2009 |
2010 |
AIDS-Associated Nephropathy
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
45
|
1
|
0.210 |
None |
1.000 |
2 |
|
2010 |
2019 |
Alopecia
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
491
|
375
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2013 |
Alopecia Areata
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
114
|
54
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2013 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.020 |
None |
1.000 |
2 |
1
|
2004 |
2007 |
Ameloblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
174
|
4
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Respiratory Tract Diseases
|
Disease or Syndrome
|
1410
|
80
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Arteriovenous fistula
|
phenotype |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Anatomical Abnormality
|
93
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Arteriovenous hemangioma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Cardiovascular Diseases
|
Neoplastic Process
|
76
|
14
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Aspartate aminotransferase measurement
|
phenotype |
|
Laboratory Procedure
|
57
|
76
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.110 |
None |
1.000 |
2 |
1
|
2011 |
2019 |
Benign Lymphoproliferative Disorder
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
3
|
0.010 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Bipolar Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1183
|
839
|
0.330 |
None |
0.750 |
4 |
|
2002 |
2012 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.400 |
None |
0.917 |
12 |
|
2010 |
2019 |
C4 complement assay (procedure)
|
phenotype |
|
Laboratory Procedure
|
12
|
15
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.050 |
None |
1.000 |
5 |
|
2001 |
2017 |